Study Completed

Prostate cancer

Bayer Identifier:

18324

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Patient characteristics, treatment patterns, and resource usage among prostate cancer patients with bone metastasis in China

Trial purpose

The primary objectives of this study were to estimate the prevalence of both all prostate cancer and of prostate cancer with bone metastasis among urban employees in Beijing and Jinan from 2011 to 2014, and to described characteristics of those with bone metastasis. The secondary objective was to describe the common treatment pattern, resource use and treatment costs of prostate cancer patients with bone metastasis in Beijing and Jinan from 2011 to 2014.

Key Participants Requirements

Sex

Male

Age

NaN - N/A

Inclusion Criteria
- prostate cancer-related words were included in the diagnosis
- the ICD-10 code was C61, C79.5 or M84.4
- the use of bisphosphonates or anti-tumor drugs, including radiation therapy drugs, chemotherapy drugs and endocrine drugs, was included in the medication administration record
- surgery or radiation therapy was included in the medical record
Exclusion Criteria
- differential diagnosis, such as Osteoporosis, fracture need to be excluded

Trial summary

Enrollment Goal

2134

Trial Dates

September 2016 - August 2017

Phase

N/A

Could I Receive a placebo

Products

Unspecified

Accepts Healthy Volunteer

Primary Outcome

Prevalence of all prostate cancer and of prostate cancer with bone metastasis
Time Frame:
Retrospective analysis of four year period
Caracteristics of patients with prostate cancer with bone metastasis
Time Frame:
Retrospective analysis of four year period

Secondary Outcome

Treatment patterns of patients with prostate cancer and bone metastasis
Time Frame:
Retrospective analysis of four year period
Costs of treatments used for patients with prostate cancer with bone metastasis
Time Frame:
Retrospective analysis of four year period

Trial design

Patient characteristics, treatment patterns, and resource usage among prostate cancer patients with bone metastasis in China

Trial Type

Observational

Intervention Type

Other

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to Bayer products.